Trial
NCT00585052
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Iowa
Collaborators
—
Condition
Ovarian Cancer
Intervention
Paclitaxel
Why stopped
Slow accrual, PI left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-05